Susan J. Ramus - Concepedia

Author

Susan J. Ramus

Also Known As

A M Near, A. Difeo, Ake Borg, Aleksandra Gentry-Maharaj, Alicja Wolk, Aline Talhouk, Amy Pearn, Andrew Berchuck, Anna DeFazio, Anthony J Swerdlow

757

Publications

23.4K

Citations

H-Index

Concepts

All Affiliations

University of Cambridge University College London Roswell Park Comprehensive Cancer Center University of Southern California QIMR Berghofer Medical Research Institute

About

Susan J. Ramus is an author at University of Cambridge specializing in medicine, ovarian cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	52	3.3K
2	Public Health	18	21	1.3K
3	Biostatistics	2	2	40
4	Engineering	1	1	30
5	Social Sciences	1	1	15

Susan J. Ramus

152

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies Celeste Leigh Pearce, Claire Templeman, Mary Anne Rossing, The Lancet Oncology	2012	912
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer Andrew E. Teschendorff, Usha Menon, Aleksandra Gentry‐Maharaj, Genome Research	2010	879
Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA) Nasim Mavaddat, Daniel Barrowdale, Irene L. Andrulis, Cancer Epidemiology Biomarkers & Prevention	2012	649
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer Susan J. Ramus, Honglin Song, Ed Dicks, JNCI Journal of the National Cancer Institute	2015	432
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study Weiva Sieh, Martin Köbel, Teri A. Longacre, The Lancet Oncology Ovarian Cancer SurvivalMedicineHormonal ReceptorPathologyGynecology	2013	423
Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families Xin Yang, Goska Leslie, Alicja Doroszuk, Journal of Clinical Oncology	2019	393
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli, JAMA Oncology	2017	388
An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer Andrew E. Teschendorff, Usha Menon, Aleksandra Gentry‐Maharaj, PLoS ONE	2009	376
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers Karoline Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, JNCI Journal of the National Cancer Institute	2016	338
Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Simon A. Gayther, Kylie L. Gorringe, Susan J. Ramus, PubMed Tumor BiologyEsophageal CancerGastrointestinal OncologyMedicineGenetics	1998	327

Page 1